Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

Randolph Evans; H. D. Hoffman

Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	679-680
Number of pages	2
Journal	Headache
Volume	39
Issue number	9
State	Published - Dec 20 1999

ASJC Scopus subject areas

Neurology
Clinical Neurology

Cite this

@article{58442c77e1fd48f79c718a8fc74037f7,

title = "Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)",

author = "Randolph Evans and Hoffman, {H. D.}",

year = "1999",

month = dec,

day = "20",

language = "English (US)",

volume = "39",

pages = "679--680",

journal = "Headache",

issn = "0017-8748",

publisher = "Wiley",

number = "9",

}

TY - JOUR

T1 - Warning

T2 - The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

AU - Evans, Randolph

AU - Hoffman, H. D.

PY - 1999/12/20

Y1 - 1999/12/20

UR - http://www.scopus.com/inward/record.url?scp=0032738745&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032738745&partnerID=8YFLogxK

M3 - Letter

C2 - 11279966

AN - SCOPUS:0032738745

SN - 0017-8748

VL - 39

SP - 679

EP - 680

JO - Headache

JF - Headache

IS - 9

ER -

Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

ASJC Scopus subject areas

Other files and links

Cite this